Acurx Pharmaceuticals Renews Media Partnership with Leading Business TV Platform

New to The Street, one of the leading U.S. business television platforms, has announced the renewal of its media partnership with Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), a late-stage biopharmaceutical company. The new series will feature continued broadcast television interviews, earned media placements, and a comprehensive outdoor advertising campaign, further expanding the reach and visibility of Acurx Pharmaceuticals' innovative solutions.

Amplifying the Acurx Pharmaceuticals Story Across Multiple Platforms

Continued Broadcast Television Interviews

The renewed partnership with New to The Street will provide Acurx Pharmaceuticals with a valuable platform to share its story and showcase its advancements in the biopharmaceutical industry. Through a series of broadcast television interviews, the company will have the opportunity to engage with a wide audience, highlighting its latest developments, clinical trials, and the potential impact of its innovative treatments.These interviews will serve as a powerful tool to educate viewers, build brand awareness, and position Acurx Pharmaceuticals as a leader in the field. By leveraging the reach and credibility of New to The Street's business television platform, the company can effectively communicate its unique value proposition and connect with potential investors, partners, and industry stakeholders.

Earned Media Placements

In addition to the broadcast television interviews, the renewed partnership will also focus on securing earned media placements for Acurx Pharmaceuticals. Through strategic media outreach and collaboration with New to The Street's experienced team, the company will be able to secure valuable coverage in reputable news outlets and industry publications.These earned media placements will further amplify the Acurx Pharmaceuticals story, providing third-party validation and enhancing the company's credibility. By appearing in respected media channels, Acurx Pharmaceuticals can reach a broader audience, generate increased awareness, and position itself as a thought leader in the biopharmaceutical space.

Comprehensive Outdoor Advertising Campaign

Complementing the broadcast television interviews and earned media placements, the renewed partnership will also include a comprehensive outdoor advertising campaign. This multi-faceted approach will leverage various outdoor advertising channels, such as billboards, digital displays, and strategic placements in high-traffic locations.The outdoor advertising campaign will serve to further elevate the Acurx Pharmaceuticals brand and increase its visibility among key stakeholders, including potential investors, industry peers, and the general public. By strategically placing its messaging in prominent outdoor locations, the company can effectively reach and engage with a diverse audience, reinforcing its position as a leading player in the biopharmaceutical industry.

Expanding Reach and Visibility

The renewed partnership between Acurx Pharmaceuticals and New to The Street represents a strategic move to amplify the company's story and expand its reach across multiple platforms. By leveraging the power of broadcast television, earned media placements, and a comprehensive outdoor advertising campaign, Acurx Pharmaceuticals can effectively communicate its value proposition, showcase its innovative solutions, and connect with a wider audience.This multi-faceted approach will not only enhance the company's brand recognition but also provide valuable opportunities to engage with potential investors, industry partners, and the broader healthcare community. As Acurx Pharmaceuticals continues to advance its clinical trials and pipeline, this renewed partnership with New to The Street will play a crucial role in driving increased awareness, fostering meaningful connections, and positioning the company for long-term success.